AIM
EXAS

Advantage Investment Management’s Exact Sciences EXAS Stock Holding History

Advantage Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$6K – 1033
2018
Q2 		$6K Buy
+100
New +$5.38K ﹤0.01% 733

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advantage Investment Management's EXAS Position: Q3 2018 in Review

Advantage Investment Management sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 100 shares — an estimated $6K sold.

Advantage Investment Management first reported a position in EXAS in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 365 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

  • Advantage Investment Management reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
  • Advantage Investment Management sold 100 Exact Sciences shares in Q3 2018, an estimated $6K.
  • Advantage Investment Management first reported a position in Exact Sciences in Q2 2018 and held it in 1 quarter.
  • Advantage Investment Management's Exact Sciences position peaked at $6K in Q2 2018.
  • 365 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Advantage Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.